What is Arcus Biosciences's change in other assets?

Arcus Biosciences (RCUS) reported change in other assets of $3M in Q1 2026.

What is the long-term trend for Arcus Biosciences's change in other assets?

Over 3 years (2021 to 2025), Arcus Biosciences's change in other assets has grown at a 18.6% compound annual growth rate (CAGR), from $3M to -$5M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Arcus Biosciences RCUS Change in Other Assets

Change in Other Assets at other companies

IDEAYA Biosciences, Inc.IDYA

-$3.03M-254%

IncyteINCY

-$9.19M-115%

ImmunityBio, Inc.IBRX

$1.05M+1,152%

Summit TherapeuticsSMMT

$1.03M-27.7%

Cogent Biosciences, Inc.COGT

$1.84M+184%

CRISPR TherapeuticsCRSP

$247K-61.0%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's change in other assets?: Arcus Biosciences (RCUS) reported change in other assets of $3M in Q1 2026.
What is the long-term trend for Arcus Biosciences's change in other assets?: Over 3 years (2021 to 2025), Arcus Biosciences's change in other assets has grown at a 18.6% compound annual growth rate (CAGR), from $3M to -$5M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.